Fundraising Fox

Pronutria Biosciences

Cambridge, US · Delaware corporation · 4 known investors

Biotech

Founders & leadership

RC
Robert ConnellyExecutive
GM
Garry MenzelExecutive
JM
Jeff MooreExecutive

Board

JM
John MendleinBoard director
DBDavid Berry
David Berryin𝕏Board directorGeneral Partner at Flagship Pioneering
NANoubar Afeyan
Noubar Afeyanin𝕏Board directorInvestor at Flagship Pioneering
PB
Peter Barton HuttBoard director
CC
Charles CooneyBoard director
GB
Gregory BeharBoard director
SH
Stephen HogeBoard director
CV
Chris ViehbacherBoard director
GP
Gary PisanoBoard director

Investors · 4

Fidelity InvestmentsreportedBoston
Flagship PioneeringreportedCambridge · $500K – $10Mvia Noubar Afeyan · board
Flagship VenturesreportedCambridge
SynconareportedLondonvia Paul Sekhri · board

Reported raises · per SEC filings

Form D private placements

$92.8M disclosed across 3 rounds · 2015–2022

▶$6MraisedSep 2022 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William HinshawExecutive Officer, Director
  • Paul SekhriDirector
  • Martin HendrixDirector
  • Cristina M. RondinoneDirector
  • Margaret KozielExecutive Officer
  • Virginia DeanExecutive Officer
  • Gary PisanoDirector
  • David R. EpsteinDirector
  • Robert CraneExecutive Officer
  • Catherine A. SohnDirector
  • William D. BairdDirector
  • Paul FehlnerExecutive Officer
  • Michael RosenblattDirector
Offering amount
$12M
Amount sold
$6M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$42.5MraisedFeb 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert ConnellyExecutive Officer, Director
  • John MendleinDirector
  • Peter Barton HuttDirector
  • Noubar AfeyanDirector
  • Stephen HogeDirector
  • Gary PisanoDirector
  • Charles CooneyDirector
  • Gregory BeharDirector
  • Chris ViehbacherDirector
  • David BerryDirector
  • Jeff MooreExecutive Officer
Amount sold
$42.5M
First sale
Feb 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$44.3MraisedFeb 2016 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert ConnellyExecutive Officer, Director
  • Garry MenzelExecutive Officer
  • John MendleinDirector
  • Peter Barton HuttDirector
  • David BerryDirector
  • Jeff MooreExecutive Officer
  • Charles CooneyDirector
  • Gregory BeharDirector
  • Stephen HogeDirector
  • Noubar AfeyanDirector
  • Chris ViehbacherDirector
  • Gary PisanoDirector
Amount sold
$44.3M
First sale
Jan 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Pronutria Biosciences went on to found or lead other companies.

Noubar AfeyanDirectorFounded ProFound Therapeutics +13David BerryDirectorFounded Valo

In the news

Nestlé nurtures Pronutria with $42.5m -globalventuring.com · Feb 2016Pronutria Biosciences Completes $42.5M Funding - FinSMEsfinsmes.com · Feb 2016Nestlé pays $42.5M to buy into Pronutria as it blazes a trail to pivotal data | Fierce Biotechfiercebiotech.com · Feb 2016What to Know About Pronutria Biosciences - BioSpacebiospace.com · Sep 2015A nutraceutical biologic for anorexia? Pronutria Biosciences closes $39M Series Cmedcitynews.com · May 2015Pronutria Biosciences Completes $39M Series C Financing - FinSMEsfinsmes.com · May 2015

Frequently asked questions

Who are Pronutria Biosciences's investors?
Pronutria Biosciences's investors include Fidelity Investments, Flagship Pioneering, Flagship Ventures, Syncona.
How much funding has Pronutria Biosciences raised?
Pronutria Biosciences has disclosed $92.8M raised across 3 rounds.
Where is Pronutria Biosciences headquartered?
Pronutria Biosciences is headquartered in Cambridge, US.